These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16864474)

  • 1. Clinician validation of Poison Control Center (PCC) intentional exposure cases involving prescription opioids.
    Smith MY; Dart R; Hughes A; Geller A; Senay E; Woody G; Colucci S
    Am J Drug Alcohol Abuse; 2006; 32(3):465-78. PubMed ID: 16864474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison.
    Hughes AA; Bogdan GM; Dart RC
    Clin Toxicol (Phila); 2007; 45(2):144-51. PubMed ID: 17364631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone.
    Bailey JE; Barton PL; Lezotte D; Lowenstein SR; Dart RC
    Drug Alcohol Depend; 2006 Sep; 84(2):182-7. PubMed ID: 16510252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
    Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
    Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of temporal changes of abuse and misuse of prescription opioids.
    Spiller H; Bailey JE; Dart RC; Spiller SS
    J Addict Dis; 2010 Jan; 29(1):78-83. PubMed ID: 20390701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of quetiapine abuse and misuse reported to poison centers.
    Klein-Schwartz W; Schwartz EK; Anderson BD
    J Addict Med; 2014; 8(3):195-8. PubMed ID: 24662370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.
    Becker WC; Sullivan LE; Tetrault JM; Desai RA; Fiellin DA
    Drug Alcohol Depend; 2008 Apr; 94(1-3):38-47. PubMed ID: 18063321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of medication identification requests managed by a U.S.-certified regional poison information center.
    Krenzelok EP; Mrvos R
    Clin Toxicol (Phila); 2009 Apr; 47(4):364-5. PubMed ID: 19365774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure reasons, other substance use, and medical outcomes of poison control center cases aged 50+ involving opioids, 2015-2020.
    Choi NG; Choi BY; DiNitto DM; Marti CN; Baker SD
    Clin Toxicol (Phila); 2022 Mar; 60(3):362-370. PubMed ID: 34404278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treated vs reported toxic exposures: discrepancies between a poison control center and a member hospital.
    Harchelroad F; Clark RF; Dean B; Krenzelok EP
    Vet Hum Toxicol; 1990 Apr; 32(2):156-9. PubMed ID: 2327066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intentional Misuse and Abuse of Loperamide: A New Look at a Drug with "Low Abuse Potential".
    Borron SW; Watts SH; Tull J; Baeza S; Diebold S; Barrow A
    J Emerg Med; 2017 Jul; 53(1):73-84. PubMed ID: 28501383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing burden of pill identification requests to US Poison Centers.
    Spiller HA; Griffith JR
    Clin Toxicol (Phila); 2009 Mar; 47(3):253-5. PubMed ID: 19225960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loperamide Trends in Abuse and Misuse Over 13 Years: 2002-2015.
    Lasoff DR; Koh CH; Corbett B; Minns AB; Cantrell FL
    Pharmacotherapy; 2017 Feb; 37(2):249-253. PubMed ID: 27995643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization for caffeine abuse is associated with abuse of other pharmaceutical products.
    McCarthy DM; Mycyk MB; DesLauriers CA
    Am J Emerg Med; 2008 Sep; 26(7):799-802. PubMed ID: 18774047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting signals of opioid analgesic abuse: application of a spatial mixed effect poisson regression model using data from a network of poison control centers.
    Smith MY; Irish W; Wang J; Haddox JD; Dart RC
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1050-9. PubMed ID: 18803336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in child and teen nonprescription drug abuse reported to a regional poison control center.
    Crouch BI; Caravati EM; Booth J
    Am J Health Syst Pharm; 2004 Jun; 61(12):1252-7. PubMed ID: 15259755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse of prescription and over-the-counter medications.
    Lessenger JE; Feinberg SD
    J Am Board Fam Med; 2008; 21(1):45-54. PubMed ID: 18178702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Scharman EJ; Erdman AR; Cobaugh DJ; Olson KR; Woolf AD; Caravati EM; Chyka PA; Booze LL; Manoguerra AS; Nelson LS; Christianson G; Troutman WG;
    Clin Toxicol (Phila); 2007; 45(7):737-52. PubMed ID: 18058301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of the misuse of prescription drugs by clients of outpatient addiction treatment centres (PHAR-MON, formerly: Ebis-med). Monitoring of medication misuse].
    Küfner H; Rösner S
    Gesundheitswesen; 2008 May; 70(5):305-14. PubMed ID: 18604769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.